Table 1.
Demographic data of patients
| Aortic Replacement Group (n =14) | Valve Replacement Group (n = 14) | p value | |||
|---|---|---|---|---|---|
| Age (years) | 68.4 ± 6.5 | 70.8 ± 7.3 | 0.1809 | ||
| Sex (M/F) | 9/5 | 10/4 | |||
| Height (cm) | 164.3 ± 10.6 | 158.9 ± 10.3 | 0.0946 | ||
| Weight (kg) | 64.8 ± 16.8 | 57.6 ± 11.3 | 0.0961 | ||
| BSA (m2) | 1.70 ± 0.24 | 1.59 ± 0.19 | 0.0892 | ||
| Cases | Ascending Aorta Replacement + AVR | 2 | MVP | 1 | |
| AVR | 2 | ||||
| Descending Aorta Replacement + CABG | 1 | AVR + TAP | 1 | ||
| Descending Aorta Replacement | 2 | AVR + MVP | 2 | ||
| TAR + AVR | 1 | AVR + MVP + CABG | 1 | ||
| TAR + CABG | 3 | AVR + MVR + TAP | 1 | ||
| TAR | 4 | AVR + CABG | 5 | ||
| Ascending Aorta Replacement + AVR + CABG | 1 | MVR + TAP | 1 | ||
| Fibrinogen (mg/dL) | 339 (274–386) | 314 (287–356) | 0.4762 | ||
| TAT (ng/mL) | 7.7 (4–14.4) | 2.1 (1.2–3.2) | 0.0009* | ||
| SFMC (μg/mL) | 20.8 (4.1–109.2) | 3.9 (2.4–4.8) | 0.0038* | ||
| FVIIa (mU/mL) | 35.0 (26.3–42.3) | 29.5 (21.3–34.8) | 0.4616 | ||
| Hemoglobin (g/dL) | 11.6 (10.5–12.9) | 11.1 (10.1–13.2) | 0.5812 | ||
| Platelet (×103/mL) | 168 (138–194) | 169 (133–190) | 0.7304 | ||
| PT-INR | 1.17 (1.11–1.24) | 1.17 (1.14–1.21) | 0.9084 | ||
| APTT (s) | 33.6 (29.8–35.1) | 34.0 (29.9–37.0) | 0.6458 | ||
AVR aortic valve replacement, MVP mitral valve plasty, MVR mitral valve replacement
TAP tricuspid annuloplasty, CABG coronary artery bypass grafting, TAR total arch replacement
*Significant difference between the two groups